Agilent announced a multi-year distribution agreement with Proscia to offer a comprehensive digital diagnostic pathology system. Combining Agilent’s trusted pathology staining solutions with Proscia’s Concentriq Dx enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality to improve patient health outcomes. Digital pathology is experiencing a new wave of adoption as laboratories seek to deliver on growing expectations for precision medicine amid a worsening pathologist shortage and rising biopsy volume. In shifting the 150-year-old standard of diagnosis from microscope to whole slide image, digital pathology enables pathologists to increasingly tap into the data contained in stained slides to make more efficient and confident decisions. Pathologists can also share patient cases remotely for peer review in real-time, further improving the quality of diagnosis and the speed of case handling. Proscia’s Concentriq Dx scalable enterprise pathology platform powers primary diagnostic workflows from individual labs to even the largest laboratory networks. It offers a pathologist-centric user experience across a digital environment for viewing, managing, and analyzing images.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on A:
